BMC urology · 2025
The endoscopic surgical monitoring system-guided impact factors exploring of blood loss and fluid absorption during plasmakinetic TURP: a prospective study in high-risk BPH patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jin Qi, Zhang Jiaodi, Wang Guilin, Zhang Yunxin, Zhai Zhenxing, Yi Aizhang, Ding Yongqiang, Bai Jiangtao, Zheng Qihui, Jin Wenjun, Zhang Luyang, Jia Haitao, Guo Ting, Dong Zhilong, Tian Junqiang, Mi Jun, Wang Zhiping
Аннотация
OBJECTIVE: To determine impact factors affecting intraoperative blood loss and fluid absorption by utilizing a novel endoscopic surgical monitoring system (ESMS) for objective quantification in high-risk benign prostatic hyperplasia (BPH) patients undergoing transurethral plasmakinetic resection of the prostate (PK-TURP).
METHODS: This prospective cohort study enrolled 512 high-risk BPH patients undergoing PK-TURP. The ESMS was employed to monitor blood loss and fluid absorption in real-time and non-invasively during the surgery. Univariable and multivariable linear and logistic regression analyses were used to identify factors associated with blood loss (and > 300 ml) and fluid absorption (and > 1000 ml).
RESULTS: Multivariable analyses showed prostate volume, operation time, resected tissue weight, venous sinus opening and present smoking (10-20cigs/d, > 20cigs/d) were independent risk factors of blood loss and fluid absorption (all P < 0.05). Surgical capsule perforation was a significant risk factor for fluid absorption (and > 1000 ml) (B:100.47, P=0.008; OR:2.917, P=0.015). Preoperative finasteride treatment (7days-3months, >3months) and surgeon's experience (50-250 procedures, 250-500 procedures, > 500 procedures) were factors associated with lower odds of blood loss and fluid absorption (all P < 0.05).
CONCLUSION: Prostate volume, operation time, resected tissue weight, venous sinus opening, and present smoking (10-20cigs/d, > 20cigs/d) increase the risk of blood loss and fluid absorption during PK-TURP in high-risk patients. Preoperative finasteride treatment (7days-3months, >3months) and surgeon's experience (50-250 procedures, 250-500 procedures, > 500 procedures) reduce these risks, while surgical capsule perforation significantly increases fluid absorption risk. The ESMS represents an innovative tool for real-time blood loss and fluid absorption monitoring, enabling precision identification of impact factors and enhancing perioperative decision-making.
METHODS: This prospective cohort study enrolled 512 high-risk BPH patients undergoing PK-TURP. The ESMS was employed to monitor blood loss and fluid absorption in real-time and non-invasively during the surgery. Univariable and multivariable linear and logistic regression analyses were used to identify factors associated with blood loss (and > 300 ml) and fluid absorption (and > 1000 ml).
RESULTS: Multivariable analyses showed prostate volume, operation time, resected tissue weight, venous sinus opening and present smoking (10-20cigs/d, > 20cigs/d) were independent risk factors of blood loss and fluid absorption (all P < 0.05). Surgical capsule perforation was a significant risk factor for fluid absorption (and > 1000 ml) (B:100.47, P=0.008; OR:2.917, P=0.015). Preoperative finasteride treatment (7days-3months, >3months) and surgeon's experience (50-250 procedures, 250-500 procedures, > 500 procedures) were factors associated with lower odds of blood loss and fluid absorption (all P < 0.05).
CONCLUSION: Prostate volume, operation time, resected tissue weight, venous sinus opening, and present smoking (10-20cigs/d, > 20cigs/d) increase the risk of blood loss and fluid absorption during PK-TURP in high-risk patients. Preoperative finasteride treatment (7days-3months, >3months) and surgeon's experience (50-250 procedures, 250-500 procedures, > 500 procedures) reduce these risks, while surgical capsule perforation significantly increases fluid absorption risk. The ESMS represents an innovative tool for real-time blood loss and fluid absorption monitoring, enabling precision identification of impact factors and enhancing perioperative decision-making.